Sebia
Founded in 1967, SEBIA is a world’s leading provider of clinical protein electrophoresis equipment and reagents, a technology used for in-vitro diagnostics (IVD) testing.
Its systems analyse proteins in order to screen and monitor various diseases and conditions, primarily myeloma (a non-curable but partially treatable blood cancer, which typically affects people over 50 years old), genetic haemoglobin disorders, and diabetes (with its HbA1c test).
Visit Sebia